LatestOpinion: Stop asking if AI is good for medicine
Health

FDA Approves Moderna's mRNA Flu Vaccine, First of Its Kind

Helen Branswell
FDA Approves Moderna's mRNA Flu Vaccine, First of Its Kind
Summary

The FDA has approved Moderna's influenza vaccine, marking a historic milestone as the first licensed flu shot utilizing messenger RNA (mRNA) technology. This approval represents a significant advancement in vaccine development, leveraging the same proven technology platform used in Moderna's COVID-19 vaccine. The mRNA flu vaccine offers a potentially more efficient and faster production method compared to traditional egg-based flu vaccines. This development is particularly important for patients and healthcare providers seeking innovative immunization options and may improve vaccine availability and effectiveness in future flu seasons.

Stat News

Originally published on

STAT News

By Helen Branswell

Read full article(opens in new tab)

Fetched: August 6, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
Opinion: Stop asking if AI is good for medicine
Health

Opinion: Stop asking if AI is good for medicine

A new perspective challenges the common debate about whether AI is beneficial for healthcare, arguing that overgeneralizations about artificial intelligence can actually hinder the adoption of proven clinical tools. Rather than asking blanket questions about AI's value, healthcare professionals should focus on evaluating specific AI applications based on their clinical evidence and real-world effectiveness. This shift in thinking could accelerate the implementation of validated AI technologies that improve patient care and diagnostic accuracy. The opinion emphasizes that many AI tools have already demonstrated measurable benefits in specific medical contexts, and excessive skepticism risks delaying access to these advancements.

3 hours ago
STAT News
What Experts Will Examine to Verify U.S. Measles Elimination Status
Health

What Experts Will Examine to Verify U.S. Measles Elimination Status

Noel T. Brewer and colleagues will soon assess whether the United States has maintained its measles elimination status, a significant public health milestone achieved in 2000. The expert panel will evaluate surveillance data, vaccination coverage rates, outbreak response capabilities, and immune population levels to determine if the country continues to meet elimination criteria. This assessment is crucial for understanding vaccine effectiveness and identifying any gaps in immunization programs that could allow disease resurgence. Maintaining elimination status protects vulnerable populations, including infants too young for vaccination and immunocompromised individuals.

3 hours ago
STAT News
WHO: Ebola Outbreak Spreading Faster Than Response Efforts Amid Worker Strikes
Health

WHO: Ebola Outbreak Spreading Faster Than Response Efforts Amid Worker Strikes

The World Health Organization chief warned that the world's fastest-growing Ebola outbreak in Congo is spreading more rapidly than containment and treatment efforts can manage. The crisis is compounded by strikes from health workers demanding payment, which severely hampers outbreak response capabilities. Healthcare worker compensation and retention are critical to controlling infectious disease spread and protecting public health. The situation underscores how resource challenges and labor issues directly impact epidemic control and patient care delivery in affected regions.

4 hours ago
Medical Xpress
US Regulators Approve Moderna Flu Vaccine
Health

US Regulators Approve Moderna Flu Vaccine

The U.S. Food and Drug Administration (FDA) has approved Moderna's new influenza vaccine, marking a significant development in flu prevention options. This approval comes nearly six months after the FDA initially rejected the company's application for review. The new vaccine expands the portfolio of available flu vaccines for the upcoming season and offers healthcare providers and patients an additional option for annual influenza immunization. Moderna's entry into the flu vaccine market represents continued innovation in vaccine development and may increase competition among manufacturers. For Puerto Rico residents, this approval means greater vaccine availability and choice when preparing for seasonal flu protection.

4 hours ago
Medical Xpress